Ten Hong Kong Stock Institutions Recommend Anta Sports And So On.

Shengli Securities: Anta sports holding rating to HK $26

16 quarter second quarter

The amount (calculated at wholesale value) kept positive growth, showing a double-digit increase in the year, and ten consecutive quarterly orders growth from the first quarter of 14. The growth of the same store sales of Anta brand products in the third quarter of 2014 (at retail prices) showed an increase in the number of high units compared with the same period of the year.

On the whole, we are optimistic about the performance of the company in the next two years, so we will give it a rating of HK $26 and a price of HK $18.5.

China and Thailand International: 5 HK dollars for XTEP International Holdings rating

We believe that the direction of XTEP share price and the level of P / E are closely related to the growth of orders, and the order growth will also lead the company's dynamic P / E level (refer to figures 16 and 18).

In the past, when the order increased, the dynamic P / E ratio averaged 12 times. Therefore, in 2016, when the order growth rate of Q1 and Q2 orders increased from low to 10%, we believe that the company's valuation is likely to further improve at the current level.

For the first time, we covered XTEP international, gave overweight rating, and adopted the price earnings ratio pricing method, giving the target price of HK $5, corresponding to 12x times 2016 earnings ratio.

Guotai Junan International: Longyuan Power Collection rating 8 HK $

Maintain the "collection" rating but lower the target price to HK $8.

In 2015/2016/2017, the EPS forecast lowered 5.4%/1.6%/2.2%. Due to the lowered forecast of wind power utilization hours, it was partly offset by the increase in the profit contribution of the joint venture and the reduction of the average lending rate.

The new target price is equivalent to 14.6 times /11.5 times /10.2 times 2015/2016/2017 annual price earnings ratio.

Guotai Junan International: to China Zhong Wang buy rating to see HK $4.68

The company's three quarter performance in 2015 was higher than the market consensus and our estimate.

The company's revenue in the first three quarters increased by 3% to 12 billion 680 million yuan, and the net profit of shareholders increased 29.1% to RMB 2 billion 520 million yuan.

The company maintains the assumption that the output of aluminum extrusion material remains unchanged.

The expansion of the aluminum extrusion product capacity of the company has basically come to an end and at present all the production lines are running at full capacity.

The company intends to arrange more production lines to produce complex section aluminum extrusion materials with higher processing cost.

It is assumed that the processing fee is increased due to the adjustment of product structure.

The average processing cost of aluminum extrusion products will increase due to the increase in the proportion of aluminum products with more complex sections.

He maintained the target price of the company at HK $4.68 and maintained a "buy" rating.

XinDa International: promising future

The current price is equivalent to a forecast price earnings ratio of about 17.1 times in 2016, slightly higher than the average level of the industry, but its PEG is only 0.5 times, reflecting that the group's earnings growth momentum is still strong. The stock price is still rising in the short term from August to now, plus the 14 day RSI continues to climb and the MACD signal line "cow difference" expands.

Hongkong, China: $71.4, strongly recommended by Zhong Xin Pharmaceutical Co., Ltd.

It is estimated that the company's 2015-2016 EPS will be 0.74, 0.91 yuan, respectively.

Often rich, large capacity varieties, great potential to be excavated. At present, the price of stocks is seriously underestimated. We strongly recommended from the US $0.85 in December 22, 2014, and the highest price reached US $1.915. Later, with the sharp fall of A shares, the share price also dropped. We reintroduced strongly from the 1.01 US dollar in September 7th. From the basic analysis, we strongly recommend the rating, the target price is 1.4 US dollars, which is 21% higher than the current stock price, corresponding to 12 times earnings per share in 2015.

International Bank: 2.75 yuan for Jiangnan group.

The interconnection of power grids, clean energy and all roads will be the focus of development throughout 13th Five-Year. The national Power Grid Corp has begun to significantly increase investment in the 8 month period. (2) the company is developing relevant markets in the direction of the whole area. It is expected that the overseas market sales will increase 3 times in 3 years. (3) on October 18 HP, the company signed a memorandum of understanding with HC Concord to set up a joint venture to build the "Internet + cable" big data platform. (4) the investment in the State Grid increased, the overseas market grew rapidly and the market concentration increased further, and the company is expected to usher in a new round of continuous growth; (5) in view of the recent decline in copper prices, (1) UHV and intelligence

We lowered the net profit of 15/16/17 5.4%/4.4%/2.2%, lowered the target price 5.2% to 2.75 yuan, corresponding to 15 years 12 PE times, but maintained "buy" investment rating.

First Shanghai: prospects for Corelle hospital

Reference to peer situation, the company gross margin and net interest rate are at a relatively high level.

Different from other listed hospital groups, the main source of income and profit of a listed hospital is dependent on the largest self flagship hospital in Wenzhou Corelle hospital, rather than the light assets operated trusteeship hospital. The proportion of treatment cost in the income and profit structure is much higher than that in the general hospital, and the proportion of drugs is very low, which is in line with the national policy guidance.

The prevalence rate and recurrence rate of mental illness are very high. Medical risk and accident rate are low, professional barriers are high, and the industry competition pattern is better.

We believe that with the increasing prevalence and rate of mental illness, the demand for treatment will also increase steadily over the long term.

Considering the uniqueness of the company in the field and the core competitiveness of the company in the long term expansion and development, and at the same time, the pricing and valuation of the listing is more attractive than other listed companies in the same industry, we suggest the purchase of the shares.

Fortune is still on the way: the Guangzhou Automobile Group

The central government has continuously introduced new policies to support the development of new energy vehicle industry. In recent years, GAC has responded to the national call to actively develop new energy vehicle business. Besides establishing the new energy vehicle branch, it has also co operated with BYD (1211) to produce new energy buses. The joint venture company has been ordered by the Guangzhou municipal government 400 buses this year, and is believed to become a new growth point of the group's performance.

The group's stock price has exceeded 6.8 yuan resistance position, and its driving force has been rising. It has continued to rise in recent days. Under the ideal of policy support and sales growth, it can see the high line. There is still room for growth. It is recommended to buy at 7.4 yuan, with a target of 8 yuan, which will fall below 7 yuan.

Hui Li Securities: Samsonite's overweight rating to HK $28

Samsonite continues to diversify its products and brands through acquisitions, effectively expanding the competitive moat.

The firm's balance sheet, which is derived from lower financial leverage, limited capital expenditure and abundant cash flow, helps to create more competitive advantages for the company.

Of course, we also need to take a careful and objective view of the difficulties brought about by the integration of multiple businesses and the operational risks brought by the uncertainty of global economic growth.

We maintain the "overweight" rating, the 12 month target price fell slightly to HK $28, which is equivalent to 21 times and 19 times the expected price earnings ratio of 2015/2016.